These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 9426433

  • 21. [Detection of residual lesions and metastases of medullary thyroid cancer].
    Murat A.
    Ann Endocrinol (Paris); 1996; 57(1):27-32. PubMed ID: 8734286
    [Abstract] [Full Text] [Related]

  • 22. Carcinoembryonic antigen as a target for radioimmunotherapy of human medullary thyroid carcinoma: antibody processing, targeting, and experimental therapy with 131I and 90Y labeled MAbs.
    Stein R, Juweid M, Mattes MJ, Goldenberg DM.
    Cancer Biother Radiopharm; 1999 Feb; 14(1):37-47. PubMed ID: 10850286
    [Abstract] [Full Text] [Related]

  • 23. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
    Lupone G, Antonino A, Rosato A, Zenone P, Iervolino EM, Grillo M, De Palma M.
    G Chir; 2012 Feb; 33(11-12):395-9. PubMed ID: 23140924
    [Abstract] [Full Text] [Related]

  • 24. Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery.
    Arslan N, Ilgan S, Yuksel D, Serdengecti M, Bulakbasi N, Ugur O, Ozguven MA.
    Clin Nucl Med; 2001 Aug; 26(8):683-8. PubMed ID: 11452174
    [Abstract] [Full Text] [Related]

  • 25. Technetium-99m-sestamibi scanning in recurrent medullary thyroid carcinoma.
    Learoyd DL, Roach PJ, Briggs GM, Delbridge LW, Wilmshurst EG, Robinson BG.
    J Nucl Med; 1997 Feb; 38(2):227-30. PubMed ID: 9025742
    [Abstract] [Full Text] [Related]

  • 26. Radioisotope-guided surgery in patients with pheochromocytoma and recurrent medullary thyroid carcinoma: a comparison of preoperative and intraoperative tumor localization with histopathologic findings.
    Adams S, Acker P, Lorenz M, Staib-Sebler E, Hör G.
    Cancer; 2001 Jul 15; 92(2):263-70. PubMed ID: 11466678
    [Abstract] [Full Text] [Related]

  • 27. Detection of cervical metastases of thyroid medullary carcinoma by MoAb anti-CEA scintigraphy and immunohistochemistry.
    Parkkila S, Ahonen A, Torniainen P, Heikkilä J, Salmela P.
    Eur J Nucl Med; 1995 Sep 15; 22(9):1064-8. PubMed ID: 7588944
    [Abstract] [Full Text] [Related]

  • 28. Successful surgical removal of occult metastases of medullary thyroid carcinoma recurrences with the help of immunoscintigraphy and radioimmunoguided surgery.
    de Labriolle-Vaylet C, Cattan P, Sarfati E, Wioland M, Billotey C, Brochériou C, Rouvier E, de Roquancourt A, Rostène W, Askienazy S, Barbet J, Milhaud G, Gruaz-Guyon A.
    Clin Cancer Res; 2000 Feb 15; 6(2):363-71. PubMed ID: 10690512
    [Abstract] [Full Text] [Related]

  • 29. Radioimmunoimaging of non-small cell lung cancer with 111In- and 99mTc-labeled monoclonal anti-CEA-antibodies.
    Kairemo KJ, Aronen HJ, Liewendahl K, Paavonen T, Heikkonen JJ, Virkkunen P, Mäki-Hokkonen H, Karonen SL, Brownell AL, Mäntylä MJ.
    Acta Oncol; 1993 Feb 15; 32(7-8):771-8. PubMed ID: 8305225
    [Abstract] [Full Text] [Related]

  • 30. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
    Sirisriro R, Boonkitticharoen V, Kraiphibul P, Ratanatharathorn V, Sumboonnanon K, Kanjanapitak A, Kuhapremma T, Sritara C, Puchinda D, Chouplywech P, Jalayondeja V, Pekanan P, Rochanawutanon M, Intaramarn C, Ayudhya AN, Chokesuwathana P.
    Hepatogastroenterology; 2000 Feb 15; 47(32):405-13. PubMed ID: 10791201
    [Abstract] [Full Text] [Related]

  • 31. Use of somatostatin analogue scintigraphy in the localization of recurrent medullary thyroid carcinoma.
    Bernà L, Chico A, Matías-Guiu X, Mato E, Catafau A, Alonso C, Mora J, Mauricio D, Rodríguez-Espinosa J, Marí C, Flotats A, Martín JC, Estorch M, Carrió I.
    Eur J Nucl Med; 1998 Nov 15; 25(11):1482-8. PubMed ID: 9799343
    [Abstract] [Full Text] [Related]

  • 32. Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma.
    Gimm O, Ukkat J, Dralle H.
    World J Surg; 1998 Jun 15; 22(6):562-7; discussion 567-8. PubMed ID: 9597929
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Diagnosis of breast carcinoma with radiolabeled monoclonal antibodies (MoAbs) to carcinoembryonic antigen (CEA) and human milk fat globulin (HMFG).
    Rosner D, Nabi H, Wild L, Ortman-Nabi J, Hreshchyshyn MM.
    Cancer Invest; 1995 Jun 15; 13(6):573-82. PubMed ID: 7583706
    [Abstract] [Full Text] [Related]

  • 35. Contribution of different scintigraphic techniques to the management of medullary thyroid carcinoma.
    Sandrock D, Blossey HC, Steinroeder M, Munz DL.
    Henry Ford Hosp Med J; 1989 Jun 15; 37(3-4):173-4. PubMed ID: 2576957
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Disseminated medullary thyroid carcinoma despite early thyroid surgery in the multiple endocrine neoplasia-2A syndrome.
    van Santen HM, Aronson DC, van Trotsenburg AS, ten Kate FJ, van de Wetering MD, Wiersinga WM, de Vijlder JJ, Vulsma T.
    Thyroid; 2005 May 15; 15(5):485-8. PubMed ID: 15929671
    [Abstract] [Full Text] [Related]

  • 39. Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen. Experience with ZCE-025 and IMMU-4 monoclonal antibodies and proposed directions for clinical trials.
    Patt YZ, Podoloff DA, Curley S, Smith R, Badkhamkar VA, Lamki LM, Jessup MM, Hohn DC.
    Cancer; 1993 Jun 15; 71(12 Suppl):4293-7. PubMed ID: 8389662
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.